Cargando…
Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues
Prostate cancer (CaP) is the most common visceral malignancy and a leading cause of cancer death in men. Androgen deprivation therapy (ADT) is an established treatment for locally advanced and metastatic CaP, and often used as primary therapy in select patients. As ADT has continued to assume an imp...
Autores principales: | Bagrodia, Aditya, DiBlasio, Christopher J., Wake, Robert W., Derweesh, Ithaar H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710058/ https://www.ncbi.nlm.nih.gov/pubmed/19672340 http://dx.doi.org/10.4103/0970-1591.52907 |
Ejemplares similares
-
Nonoperative management of blunt renal trauma: Is routine early follow-up imaging necessary?
por: Malcolm, John B, et al.
Publicado: (2008) -
Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer: Prevention and Management
por: Sountoulides, Petros, et al.
Publicado: (2013) -
Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy
por: Saylor, Philip J., et al.
Publicado: (2009) -
Androgen deprivation therapy as backbone therapy in the management of prostate cancer
por: Merseburger, Axel S, et al.
Publicado: (2016) -
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer
por: Merseburger, Axel S., et al.
Publicado: (2016)